Cardiology

A once-daily dapagliflozin/saxagliptin tablet got FDA approval.

Statins are clinically proven to improve CV outcomes--a new study offers insight into the mechanisms at work on arterial plaque.

Answers to these 5 questions about patient and pending procedure create a pathway to decisions about perioperative anticoagulation.

The MD Magazine editors rounded up the 10 best stories from this month.

Janssen halted a trial of a cardiac drug early because it worked.

Regeneron/Sanofi will continue marketing, manufacturing, and selling alirocumab.

He'd seen horrors as a combat surgeon, but the Haitian earthquake was worse.

A new analysis of qualitative studies points to poor communication on multiple levels.

FOURIER trial of evolocumab shows it helps patients with atherosclerosis.

Don't drink peroxide, even if alternative medicine promotes it.

Emergency departments' experience matters in treating atrial fibrillation.

Smartphone screening for atrial fibrillation goes big in Hong Kong.

The electrode-covered vest can map the heart after capturing a single heartbeat.

FDA approved the VBX Stent Graft to treat restenotic lesions in iliac arteries.

The MD Magazine editors rounded up the 10 best stories from January—did you read them all?

Patients with insulin resistance using Actos had reduced risk of CV death.

Endotracheal intubation may do more harm than good.

Are fixed-dose antihypertensives here to stay? How does the newest combination work? Try this spot-check quiz.

The Cardiovascular Health Study identifies patient factors that can be modified to stem risk for CEA.

Drugs won't work if patients don't take them.

Cognitive assessment is not improved by lifestyle interventions in diabetes. Health is.

The frequency of hypoglycemic episodes affects carotid atherosclerosis in patients with type 1 diabetes.

Break out the blue paint for women with higher preconception blood pressure.

Heart disease risk factors, not occupation, were linked to shoulder pain.

Could cyber-terorrists turn a cardiac pacemaker into a weapon? It sounded like fiction until the FDA and a device maker today announced that they had fixed a popular device precisely to prevent that from happening.

Heartburn drugs like Prilosec and Nexium might alleviate acid reflux, but could raise the risk of severe stomach infections.

In a dramatic decision on a long-running patent dispute over alirocumab vs. evolocumab, a federal court judge ruled that Amgen's patents were violated and that rivals Sanofi/Regeneron can no longer distribute their product.

The lifesaving potential in a statin Rx should motivate us to try, try again if side effects lead to discontinuation.

Should physicians critically reconsider their management strategy for ACS in a broad spectrum of patients with ACS

The MD Magazine editors rounded up the 10 best stories from December—did you read them all?